# Paenitracins, a novel family of bacitracin-type nonribosomal peptide antibiotics produced by plant-associated Paenibacillus species

**Authors:** Nataliia V. Machushynets, Somayah S. Elsayed, Chao Du, Vladyslav Lysenko, Mercedes de la Cruz, Pilar Sanchez, Olga Genilloud, Nathaniel I. Martin, Mark R. Liles, Gilles P. van Wezel

PMC · DOI: 10.1128/msystems.01496-25 · 2026-02-17

## TL;DR

Researchers discovered a new family of antibiotics called paenitracins from plant-associated Paenibacillus bacteria, which show promise against drug-resistant pathogens.

## Contribution

A novel MassQL-based workflow was developed to identify bioactive nonribosomal peptides in Paenibacillus, leading to the discovery of paenitracins.

## Key findings

- Paenitracins are the first bacitracin-type peptides identified in Paenibacillus.
- They exhibit potent activity against gram-positive pathogens like vancomycin-resistant Enterococcus faecium.
- The discovery pipeline enables systematic prioritization of bioactive nonribosomal peptides.

## Abstract

The growing threat of antimicrobial resistance necessitates the discovery of novel antibiotics with activity against drug-resistant pathogens. Members of the genus Paenibacillus are a rich source of nonribosomal peptides (NRPs), including well-known antibiotics such as polymyxins, paenibacterin, and tridecaptins. Here, we use a targeted mass spectrometry query language (MassQL)-based approach to identify the NRPs produced by a collection of 227 taxonomically diverse plant-associated Paenibacillus strains, providing detailed insights into their NRP-producing potential. Using MassQL to zoom in specifically on NRPs containing basic amino acids, we discovered a novel family of bacitracins, which we designated paenitracins. The paenitracins are the first bacitracin-type peptides reported in Paenibacillus and are distinguished from canonical bacitracins by three previously unseen amino acid substitutions. The paenitracins exhibit potent activity against gram-positive pathogens, including vancomycin-resistant Enterococcus faecium E155. Our work provides a novel metabolomics-guided and genomics-guided workflow for the discovery of bioactive NRPs as a strategy to prioritize natural product chemical space and accelerate antibiotic discovery.

Members of the genus Paenibacillus play an important role in soil ecology, producing a range of important nonribosomal peptides (NRPs). A collection of plant-associated Paenibacillus spp. were analyzed for their phylogenetic and metabolic diversity. We developed a novel discovery pipeline that combines feature-based molecular networking with mass spectrometry query language queries to systematically prioritize bioactive NRPs containing basic amino acids. Thus, we provide a comprehensive genus-wide inventory of NRPs produced by Paenibacillus spp. We thereby identified the paenitracins, a new sub-family of bacitracins active against multidrug-resistant gram-positive pathogens. Our pipeline enables the discovery of novel peptidic natural products to accelerate the prioritization of chemical space for antibiotics.

## Linked entities

- **Species:** Paenibacillus (taxon 44249)

## Full-text entities

- **Diseases:** positive (MESH:D000377)
- **Chemicals:** bacitracin (MESH:D001414), tridecaptins (MESH:C017770), amino acids (MESH:D000596), NRP (-), paenibacterin (MESH:C577323), vancomycin (MESH:D014640)
- **Species:** Enterococcus faecium E155 (strain) [taxon 1303769], Paenibacillus (genus) [taxon 44249]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13011432/full.md

---
Source: https://tomesphere.com/paper/PMC13011432